Here’s the latest on ESI/Tricare recoupment

NCPA June 29, 2020

NCPA understands that some pharmacies have received letters from Express Scripts stating that ESI has been directed by the Defense Health Agency to suspend recoupment actions focused on Tricare compound prescriptions as previously reported. We are working with our partners to get more details and we are in active discussion with Tricare leadership. We’ll pass along additional information as we receive it.